Page 597«..1020..596597598599..610620..»

Stem Cell Lines and Paid-for Eggs: Stem Cell Agency Delays Action on Easing Restrictions

By Dr. Matthew Watson

A key panel of the California stem cell
agency today balked at approving a plan to ease restrictions on
using stem cell lines derived from women who were paid for their
eggs.
The proposal had been scheduled to be
taken up tomorrow by the governing board of the $3 billion agency,
but the board's standards working group delayed action.
In response to a question, Kevin
McCormack
, a spokesman for the agency, said in an email,

“It was felt that more discussion
was needed before moving to a vote so another meeting is going to be
scheduled.”

In 2006, the CIRM governing board
approved regulations that banned the use of CIRM funds for stem cells
lines derived using compensation. That rule would be modified under
today's plan, which would permit the CIRM governing board to approve
the use of such lines following a staff study evaluating scientific and ethical issues.
Their use would be allowed if the lines would “advance CIRM's
mission.”

The delay came after four
organizations, including the Center for Genetics and Society in
Berkeley, argued that the plan is vague and did not adequately
address safety issues.
The four-page statement by the groups
said that the plan does not appear to have met “numerous concerns”
raised in 2009 in a document co-authored by the CIRM staff. Those
concerns include long-term risk and ethical issues.
Under the proposal, the groups said
that the agency governing board

“...will decide whether to approve a
grantee’s request to use a stem cell line created with paid-for
eggs on the basis of whether doing so 'will advance CIRM’s
mission.' This criterion is much too vague, and doesn’t include
consideration of the health or welfare of the women who undergo egg
retrieval. Protecting the well-being of women providing eggs is not
even mentioned (though perhaps it could be considered as an element
of the fifth of five 'factors to be considered by the ICOC(the agency
board),' 'whether the donation…was consistent with `best practices’
at the time of donation').”

The standards group also heard from a
UCLA researcher who argued on behalf of the change. Kathrin Plath
said she and her colleagues wanted to use a paid-for stem cell line
from the Oregon experiment that cloned human stem cells.

(An earlier version of this item said the change under consideration would ease restrictions on "purchasing" stem cell lines. The word "purchasing" was changed to "using.")
Here is the text of the statement by
the four organizations.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/QECOGHuAvIc/stem-cell-lines-and-paid-for-eggs-stem.html

To Read More: Stem Cell Lines and Paid-for Eggs: Stem Cell Agency Delays Action on Easing Restrictions
categoriaStem Cell Therapy commentoComments Off on Stem Cell Lines and Paid-for Eggs: Stem Cell Agency Delays Action on Easing Restrictions | dataJuly 28th, 2013
Read All

$70 Million Alpha Stem Cell Clinic Project Garners Mainstream Media Attention

By Dr. Matthew Watson

California's $70 million plan for a
chain of “Alpha” stem cell clinics today received its first major
attention from the mainstream media.
The story came in the state's largest
circulation newspaper, appearing this morning on the home page of the
website of Los Angeles Times.
The Alpha project would create five clinics
around the state and a coordination/information center under a
concept that comes before the governing board of the state's $3
billion stem cell agency at its meeting tomorrow in Burlingame, Ca. Funds could be
awarded as early as a year from now. (For more information, see here
and here.)
Reporter Eryn Brown quoted Natalie
DeWitt
, special projects officer for CIRM, as the stem cell agency is known, and Maria Millan, a CIRM
medical officer. Brown wrote,

“Clinics to conduct trials of stem
cell therapies have different needs than clinics designed to deliver
conventional therapies, DeWitt and Millan said. They need special
facilities for handling the cells safely, as well as imaging
equipment to track the cells once they're delivered into a patient’s
body.  Some of this infrastructure already exists, but other
parts of it still need to be perfected.  Establishing clinics to
house multiple trials might create the critical mass needed to get
the infrastructure in place, they said....

"Additionally, they said, CIRM
hopes that such collaboration would encourage stem cell companies to
share information -- speeding their own work and also helping out
policymakers and insurers who are trying to figure out how they'll
pay for stem cell therapies in the future.”

The Times quoted the
California Stem Cell Report as saying last week,

 “The Alpha clinics
are aimed at creation of a sturdy foundation for the stem cell
industry in California, capitalizing on the burgeoning, international
lure of stem cell treatments.”

The proposal envisions Alpha stem cell
clinics at major, established institutions around the state. It is
possible that two could be located in the Los Angeles area at
institutions such as UCLA, USC, Cedars-Sinai or the City of Hope, all
of which have representatives on the stem cell agency's governing
board. Other likely locations are in the San Francisco Bay area and
San Diego, again at facilities such as Stanford, UC San Francisco and
UC San Diego that have representation on the agency board.

Institutions competing for the grants,
including businesses, will be subject to closed-door. peer review
prior to final action by the full governing board.  

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/s_-mm4nTU_0/70-million-alpha-stem-cell-clinic.html

To Read More: $70 Million Alpha Stem Cell Clinic Project Garners Mainstream Media Attention
categoriaStem Cell Therapy commentoComments Off on $70 Million Alpha Stem Cell Clinic Project Garners Mainstream Media Attention | dataJuly 28th, 2013
Read All

UCLA Researcher Calls for Easing of Restrictions on Stem Cell Lines Derived from Eggs From Paid Providers

By Dr. Matthew Watson

A UCLA researcher has spoken out in
support of a proposal to allow use of California stem cell agency
funds to purchase stem cell lines derived from eggs provided by women
who have been paid for the service.
Kathrin Plath, an associate professor, said in a letter to the agency that she and her colleagues would like to use a line from the Oregon SCNT
experiment by Shoukhrat Mitalipov in which human stem cells were cloned. Currently agency funds cannot be used for that purpose as
a result of regulations that are the extension of a state law that
bars use of agency funds for payment for eggs.
The agency's standards group meets later today to consider changing those regulations. The proposal will
then go before the full board tomorrow.
Plath, who has received $5 million from CIRM, said,

“In my lab, we are ... interested in
understanding what happens to the somatically silenced X chromosome
when differentiated cells are reprogrammed by SCNT. The key question
is: are these SCNT-ESCs more similar to iPSCs or
fertilization-derived ESCs with respect to the epigenetic state of
the X chromosome. Furthermore, it has been shown in mouse
reprogramming that the active X chromosome becomes deregulated during
SCNT-based reprogramming, and we would like to address this problem
in the human system as well.

“We believe that the comparison of
the epigenetic states between fertilization-derived ESCs, SCNT-ESCs
and human iPSCs is important for a better characterization of these
cells and understanding of their epigenetic nature.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/2YTtgbJCtRw/ucla-researcher-calls-for-easing-of.html

To Read More: UCLA Researcher Calls for Easing of Restrictions on Stem Cell Lines Derived from Eggs From Paid Providers
categoriaStem Cell Therapy commentoComments Off on UCLA Researcher Calls for Easing of Restrictions on Stem Cell Lines Derived from Eggs From Paid Providers | dataJuly 28th, 2013
Read All

‘Frankenstein’s Cat’ poses ethical questions about biotechnology – South China Morning Post

By Dr. Matthew Watson

'Frankenstein's Cat' poses ethical questions about biotechnology
South China Morning Post
Here's a cheery fact: between acts of war and more diabetes, the number of human amputees is expected to grow around 40 percent by 2020. This I learned from Frankenstein's Cat: Cuddling Up to Biotech's Brave New Beasts by Emily Anthes, a book I picked ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG0ZtamXfkI1WB2Zu6tyZuADMt4Ag&url=http://www.scmp.com/lifestyle/technology/article/1292150/frankensteins-cat-poses-ethical-questions-about-biotechnology

To Read More: ‘Frankenstein’s Cat’ poses ethical questions about biotechnology – South China Morning Post
categoriaUncategorized commentoComments Off on ‘Frankenstein’s Cat’ poses ethical questions about biotechnology – South China Morning Post | dataJuly 27th, 2013
Read All

FAQ4 A Scientific Basis for Stem Cell Therapy – Video

By Dr. Matthew Watson


FAQ4 A Scientific Basis for Stem Cell Therapy
http://youtu.be/uf_toA9Nzuo With all the hype online and in the media today, it is easy to believe that Stem Cell therapy is ALSO #39;hype #39;, but it actually eme...

By: Kerry Dean

Go here to read the rest:
FAQ4 A Scientific Basis for Stem Cell Therapy - Video

To Read More: FAQ4 A Scientific Basis for Stem Cell Therapy – Video
categoriaUncategorized commentoComments Off on FAQ4 A Scientific Basis for Stem Cell Therapy – Video | dataJuly 26th, 2013
Read All

Oklahoma Veterinarian Offering Stem Cell Therapy For Aging Pets

By Sykes24Tracey

TULSA, Oklahoma -

A controversial therapy that's not available for humans is being used on their pets. Stem cells are helping dogs and cats heal faster and get rid of pain as the animals get older.

Mandy Clinton loves her dog and she'd do just about anything for her.

"I've had her for 14 years. She's my homegirl," Clinton said about Libbi.

But Libbi has come up with a hitch in her giddy up. She tripped while walking up the stairs and tore her ACL.

Clinton was looking into surgery when she learned about stem cell therapy and its ability to help dogs heal faster and reduce pain.

"I had no idea. I had no idea. It blew my mind, but I've had Libbi for 14 years, and so I was ready to do it if it was possible," she said.

Dr. Joe Landers at Heritage Veterinary Hospital will be performing Libbi's surgery on Wednesday.

They'll harvest stem cells from Libbi's stomach, process and stimulate them, then implant the stem cells on her leg joint.

"If you've ever cut your skin, deeply with a knife or something, you've had stem cell repair," said Dr. Joe Landers, DVM.

Read more from the original source:
Oklahoma Veterinarian Offering Stem Cell Therapy For Aging Pets

To Read More: Oklahoma Veterinarian Offering Stem Cell Therapy For Aging Pets
categoriaUncategorized commentoComments Off on Oklahoma Veterinarian Offering Stem Cell Therapy For Aging Pets | dataJuly 23rd, 2013
Read All

Stem Cell Therapy Used as Dog Arthritis Treatment – Video

By Dr. Matthew Watson


Stem Cell Therapy Used as Dog Arthritis Treatment
We have dedicated our careers to helping dogs live to the fullest extent possible. For more information please visit one of our articles below: Dog Arthritis...

By: Duncan Bulow

See the original post:
Stem Cell Therapy Used as Dog Arthritis Treatment - Video

To Read More: Stem Cell Therapy Used as Dog Arthritis Treatment – Video
categoriaUncategorized commentoComments Off on Stem Cell Therapy Used as Dog Arthritis Treatment – Video | dataJuly 22nd, 2013
Read All

Arthritis Treatment Center What is Stem Cell Therapy – Video

By raymumme


Arthritis Treatment Center What is Stem Cell Therapy
http://www.arthritistreatmentcenter.com/what_stem_cell.html - This facts will truly surprise you and your family.

By: Joseph Richardson

Read the original post:
Arthritis Treatment Center What is Stem Cell Therapy - Video

To Read More: Arthritis Treatment Center What is Stem Cell Therapy – Video
categoriaUncategorized commentoComments Off on Arthritis Treatment Center What is Stem Cell Therapy – Video | dataJuly 22nd, 2013
Read All

Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries

By JoanneRUSSELL25

(PRWEB) July 22, 2013

The Institute of Regenerative and Molecular Orthopaedics (IRMO), world-renowned stem cell therapy experts, applauds the use of stem cell therapy for treatment of spinal injuries. In recent times, stem cell therapy has been increasingly sought after to support treatments of various injuries, especially in the sports world. Its use in repairing spinal injuries comes as good news to the thousands of Americans currently living with spinal cord injuries who are seeking the latest in breakthrough medical solutions.

Stem cell therapy is of the most exciting and promising treatments in modern medicine. Inroads are made every day, as the many applications of stem cell treatments become better understood by medical professionals around the world. Experts, like Dr. Joseph Purita of the Institute of Regenerative and Molecular Orthopaedics, have been utilizing stem cell treatments for many years to treat sports injuries.

Recent scientific and technological advancements have made stem cell extraction relatively inexpensive and accessible. Today, medical professionals have unprecedented access to these remarkable cells and are increasingly applying them in new ways to better aid in the bodys repair process. This includes advances in platelet rich plasma therapy (PRP), a process that takes a concentration of a persons own plasma and injects it into areas in need of new growth and tissue repair.

The use of stem cell therapy in the treatment of spinal cord injuries presents probably the biggest challenge yet for proponents of the treatment. Researchers are increasingly using stem cells to hopefully better understand its capabilities. The hope for spinal cord injuries is that one day stem cells can be used to generate new passageways for nerve signals to connect to muscles. The more stem cells are used for treatment in spinal cord injuries, the closer the medical field will be to fulfilling this promise.

Headed by the world-renowned stem cell treatment pioneer, Dr. Purita, the Institute of Regenerative and Molecular Orthopaedics is continually advancing the world of stem cell therapy treatments. They are one of the few orthopedic practices in existence that utilizes stem cell therapy, and PRP therapy, with orthopedic surgery to maximize a patients recovery outcome. As more stem cell treatments are being used to treat spinal injuries, Dr. Purita and his group look forward to seeing what great strides are made in battling the crippling condition in the near future.

About Stem Cell Orthopedic: The Institute of Regenerative and Molecular Orthopaedics (IRMO) is a world-class orthopedic practice and stem cell facility staffed with seasoned board certified orthopedic surgeons. They differ from most orthopedic practices because they offer stem cells and platelet rich plasma (PRP) therapy in conjunction with surgery or as alternative to surgical procedures. They utilize state-of-the-art technology and the latest in stem cell research to best treat their patients. IRMO uses hematopoietic stem cells (HSC), which are found circulating in blood, fat, and bone marrow, to help repair the body. They are headed by Medical Director, Dr. Joseph Purita, a world-renowned pioneer in laser orthopedic surgery and graduate of the esteemed Georgetown University Medical School. For more information, visit http://www.stemcellorthopedic.com/ or follow them on Facebook, Twitter, or YouTube.

See the original post:
Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries

To Read More: Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries
categoriaUncategorized commentoComments Off on Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries | dataJuly 22nd, 2013
Read All

De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)

By raymumme

LAST week, we discussed the potential of medical tourism in the country which will also provide opportunities for destinations like Baguio once tapped, and subject to competitive and international standards and government/ regulatory requirements.

So much has been written and reported about Stem Cell Therapy including its extraordinary promises that research holds for the treatment of a wide range of diseases and conditions.

This week, lets delve deeper.

What is Stem Cell Therapy?

Cell Therapy has been interchangeably called many names such as cellular therapy, fresh cell therapy, live cell therapy, glandular therapy, or xenograph or xenotransplant therapy.

The International Society for Stem Cell Research (ISSCR) describes stem cell therapy as a treatment that uses stem cells, or cells that come from stem cells, to replace or to repair a patients cells or tissues that are damaged. The stem cells might be put into the blood, or transplanted into the damaged tissue directly, or even recruited from the patients own tissues for self-repair.

Stem Cells have been differentiated based on where in the body or what stage in development they come from. ISCCR has enumerated them as follows (source:www.isscr.org):

1. Adult Stem Cells or Tissue-specific Stem Cells. Many adult tissues contain stem cells that can replace cells that die or restore tissue after injury. Skin, muscle, intestine and bone marrow, for example, each contain their own stem cells. In the bone marrow, billions of new blood cells are made every day from blood-forming stem cells. Adult stem cells are tissue-specific, meaning they are found in a given tissue in our bodies and generate the mature cell types within that particular tissue or organ. It is not clear whether all organs, such as the heart, contain stem cells. The term adult stem cells is often used very broadly and may include fetal and cord blood stem cells.

Another type of adult stem cell is the mesenchymal stem cell. These are found in a number of tissues, including bone marrow, and may be able to produce bone, cartilage and fat. It is also possible that these or similar cells may aid in the regeneration of tissues. Extensive animal studies are currently ongoing to determine if these cells may be used for treatment of diseases such as arthritis and non-healing bone fractures. It is also possible that these or similar cells modulate the immune system in response to injury.

2. Fetal Stem Cells. Fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally tissue-specific, and generate the mature cell types within the particular tissue or organ in which they are found.

Go here to see the original:
De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)

To Read More: De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)
categoriaUncategorized commentoComments Off on De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2) | dataJuly 22nd, 2013
Read All

‘The results are profound’; Stem cell therapy used to treat animal ailments – Video

By Sykes24Tracey


#39;The results are profound #39;; Stem cell therapy used to treat animal ailments
#39;The results are profound #39;; Stem cell therapy used to treat animal ailments.

By: kgun9

Read more:
'The results are profound'; Stem cell therapy used to treat animal ailments - Video

To Read More: ‘The results are profound’; Stem cell therapy used to treat animal ailments – Video
categoriaUncategorized commentoComments Off on ‘The results are profound’; Stem cell therapy used to treat animal ailments – Video | dataJuly 21st, 2013
Read All

FAQ1-Stem Cell Therapy – Video

By Sykes24Tracey


FAQ1-Stem Cell Therapy
http://youtu.be/dJHlHBrmvrU Stem cell therapy has earned global fame for its proven ability to help sufferers of many diseases, with little ill effects or si...

By: Kerry Dean

Read the rest here:
FAQ1-Stem Cell Therapy - Video

To Read More: FAQ1-Stem Cell Therapy – Video
categoriaUncategorized commentoComments Off on FAQ1-Stem Cell Therapy – Video | dataJuly 21st, 2013
Read All

The Taste of Tomorrow: Genetic Engineering – The Daily Progress

By Dr. Matthew Watson

The Taste of Tomorrow: Genetic Engineering
The Daily Progress
Mr. Schonwald spent a considerable amount of time researching how genetic engineering might impact the salad bar of 2035. He explained, “When I started this project, I had a healthy suspicion of [genetically modified organisms]. I thought the idea of ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEQYbY4uPoh2PPEwOl9cHlvxlcE6w&url=http://www.dailyprogress.com/starexponent/opinion/columnists/the-taste-of-tomorrow-genetic-engineering/article_46728cbe-f135-11e2-b1c4-001a4bcf6878.html

To Read More: The Taste of Tomorrow: Genetic Engineering – The Daily Progress
categoriaUncategorized commentoComments Off on The Taste of Tomorrow: Genetic Engineering – The Daily Progress | dataJuly 21st, 2013
Read All

Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For … – Forbes

By Dr. Matthew Watson

Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For ...
Forbes
That's been the reality for years at the otherwise respectable environmental news site Grist on the issue of agricultural biotechnology. This is why the current series by food writer Nathaniel Johnson reassessing Grist's own reporting on crop ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEQvG01E91WBSat7A7yxPXBT-mvDw&url=http://www.forbes.com/sites/jonentine/2013/07/18/grist-challenges-its-own-shaky-crop-biotechnology-reporting-sets-stage-for-gmo-science-journalism-conclave/

To Read More: Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For … – Forbes
categoriaUncategorized commentoComments Off on Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For … – Forbes | dataJuly 21st, 2013
Read All

Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized – Forbes

By Dr. Matthew Watson

Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized
Forbes
Investors considering a purchase of Puma Biotechnology Puma Biotechnology, Inc. (NYSE: PBYI) shares, but cautious about paying the going market price of $53.61/share, might benefit from considering selling puts among the alternative strategies at their ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE8wH6oYamtnfJeeqKImWmmETyysg&url=http://www.forbes.com/sites/stockoptionschannel/2013/07/19/commit-to-purchase-puma-biotechnology-at-45-earn-14-8-annualized/

To Read More: Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized – Forbes
categoriaUncategorized commentoComments Off on Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized – Forbes | dataJuly 21st, 2013
Read All

Biotechnology – Revolutions with Jon Faine – ABC Local

By Dr. Matthew Watson


ABC Local
Biotechnology - Revolutions with Jon Faine
ABC Local
This week Revolutions looks at the new possibilities opened up by biotechnology and talks to listeners about the procedures they've had, procedures that would have been thought impossible just a few decades ago. Joining Jon Faine for the discussion is ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHbYUicn77XJenta8Cy9-N7CQuRAA&url=http://www.abc.net.au/local/audio/2013/07/19/3806579.htm

To Read More: Biotechnology – Revolutions with Jon Faine – ABC Local
categoriaUncategorized commentoComments Off on Biotechnology – Revolutions with Jon Faine – ABC Local | dataJuly 21st, 2013
Read All

The real impact for healthcare and biotechnology of the Supreme Court’s … – Lexology (registration)

By Dr. Matthew Watson

The real impact for healthcare and biotechnology of the Supreme Court's ...
Lexology (registration)
On June 13, 2013, the Supreme Court issued a decision supposedly resolving the patentability of DNA in Association for Molecular Pathology v. Myriad Genetics. Immediately, all parties on both sides of the case declared victory. The American Civil ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHy0Bq5EWZbPOmsrBbWcAIHGhhQug&url=http://www.lexology.com/library/detail.aspx?g%3Db8315c4d-c049-4b49-ab76-1428f9857e98

To Read More: The real impact for healthcare and biotechnology of the Supreme Court’s … – Lexology (registration)
categoriaUncategorized commentoComments Off on The real impact for healthcare and biotechnology of the Supreme Court’s … – Lexology (registration) | dataJuly 21st, 2013
Read All

The top biotechnology companies in the Puget Sound area (slide show) – Puget Sound Business Journal (Seattle) (blog)

By Dr. Matthew Watson

The top biotechnology companies in the Puget Sound area (slide show)
Puget Sound Business Journal (Seattle) (blog)
The region's top biotechnology companies are extremely secretive about their revenues. That's one conclusion that can be drawn from the Puget Sound Business Journal's list of the top biotech firms in the area. Eleven of the top 25 companies would not ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEMHtpBMxhCboib3siqRpyxE1aWLg&url=http://www.bizjournals.com/seattle/blog/health-care-inc/2013/07/the-top-biotechnology-companies-in-the.html

To Read More: The top biotechnology companies in the Puget Sound area (slide show) – Puget Sound Business Journal (Seattle) (blog)
categoriaUncategorized commentoComments Off on The top biotechnology companies in the Puget Sound area (slide show) – Puget Sound Business Journal (Seattle) (blog) | dataJuly 21st, 2013
Read All

Biotechnology: Monsanto drops new European GM food plans – Presseurop (English)

By Dr. Matthew Watson


Los Angeles Times
Biotechnology: Monsanto drops new European GM food plans
Presseurop (English)
United States biotech giant Monsanto is ending all but one project to grow GM foods in Europe, reports German daily Die Welt. The firm announced on July 17 that it is withdrawing all permits requested to the European Commission to grow genetically ...
In Perspective: Anti-GM vitriol risesagprofessional.com
Monsanto drops GM crop plan in EUBBC News
Millions Against Monsanto: On the Road to VictoryTruth-Out
The Southern Times -Malaysia Sun
all 82 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF62I99amnqwaZLf1KbgpzT9q26yA&url=http://www.presseurop.eu/en/content/news-brief/3982351-monsanto-drops-new-european-gm-food-plans

To Read More: Biotechnology: Monsanto drops new European GM food plans – Presseurop (English)
categoriaUncategorized commentoComments Off on Biotechnology: Monsanto drops new European GM food plans – Presseurop (English) | dataJuly 21st, 2013
Read All

Applause for business achievements – Lima Ohio

By Dr. Matthew Watson

Applause for business achievements
Lima Ohio
He is a 1995 graduate of The Ohio State University with a bachelor's degree in science in molecular genetics. He then attended Kirksville College of Osteopathic Medicine in Kirksville, Mo., where he received his Doctorate of Osteopathic Medicine. In ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE1qG1KzOyosaVwURlgVg7dHERDjg&url=http://www.limaohio.com/news/business/article_76c1a974-f007-11e2-95aa-001a4bcf6878.html

To Read More: Applause for business achievements – Lima Ohio
categoriaUncategorized commentoComments Off on Applause for business achievements – Lima Ohio | dataJuly 21st, 2013
Read All

Page 597«..1020..596597598599..610620..»


Copyright :: 2025